3 Takeaways From The FDA Head's New Opioid Rx Standards
After only two months in office, U.S. Food and Drug Administration Commissioner Scott Gottlieb has unveiled a series of steps to curb the opioid crisis, including focusing on abuse-deterrent opioid options...To view the full article, register now.
Already a subscriber? Click here to view full article